创新医疗
(002173)
| 流通市值：69.57亿 | | | 总市值：72.94亿 |
| 流通股本：4.21亿 | | | 总股本：4.41亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 307,409,933.73 | 378,442,053.82 | 314,690,257.52 | 327,578,668.21 |
| 交易性金融资产 | 108,854,692.05 | 85,034,219.18 | 90,322,530.14 | 84,012,684.93 |
| 应收票据及应收账款 | 72,743,366.39 | 63,350,362.27 | 75,533,416.45 | 89,695,686.95 |
| 应收账款 | 72,743,366.39 | 63,350,362.27 | 75,533,416.45 | 89,695,686.95 |
| 预付款项 | 5,135,081.1 | 2,207,915.04 | 3,203,435.89 | 2,264,613.26 |
| 其他应收款合计 | 1,577,662.92 | 1,618,388.55 | 2,227,753.52 | 1,064,155.18 |
| 存货 | 33,725,760.48 | 32,087,978.31 | 31,588,320.15 | 36,310,179.46 |
| 其他流动资产 | 1,228,647.98 | 1,218,659.43 | 1,778,979.59 | 3,389,879.05 |
| 流动资产合计 | 530,675,144.65 | 563,959,576.6 | 519,344,693.26 | 544,315,867.04 |
| 非流动资产: | | | | |
| 长期股权投资 | 40,790,979.25 | 41,920,771.58 | 41,009,271.58 | 42,201,863 |
| 固定资产 | 1,176,329,338.87 | 1,193,637,601.93 | 1,209,830,706.83 | 1,203,661,563.46 |
| 在建工程 | 207,362.37 | 558,120 | 3,388,344.95 | 22,879,097.92 |
| 使用权资产 | 22,005,236.87 | 24,066,867.29 | 25,871,576.72 | 27,979,026.91 |
| 无形资产 | 141,522,145.14 | 143,878,135.56 | 146,317,055.13 | 148,269,099.99 |
| 商誉 | 36,881,842.88 | 36,881,842.88 | 36,881,842.88 | 36,881,842.88 |
| 长期待摊费用 | 26,097,423.24 | 27,165,350.39 | 28,348,277.92 | 30,130,000.92 |
| 递延所得税资产 | 17,235,008.92 | 16,623,824.67 | 17,217,686.21 | 17,403,846.62 |
| 其他非流动资产 | 2,503,171.22 | 844,621.22 | 106,867,689.7 | 105,394,465.73 |
| 非流动资产合计 | 1,463,572,508.76 | 1,485,577,135.52 | 1,615,732,451.92 | 1,634,800,807.43 |
| 资产总计 | 1,994,247,653.41 | 2,049,536,712.12 | 2,135,077,145.18 | 2,179,116,674.47 |
| 流动负债: | | | | |
| 短期借款 | 53,029,250 | 78,252,050 | 48,250,820 | 43,250,820 |
| 应付票据及应付账款 | 150,925,148.8 | 151,545,911.45 | 155,897,176.24 | 166,639,403.72 |
| 应付账款 | 150,925,148.8 | 151,545,911.45 | 155,897,176.24 | 166,639,403.72 |
| 预收款项 | - | 16,686.67 | 34,186.67 | 34,186.67 |
| 合同负债 | 2,800,444.99 | 2,593,631.43 | 2,894,717.09 | 3,394,614.52 |
| 应付职工薪酬 | 39,136,223.3 | 35,604,409.51 | 32,816,429.86 | 46,173,153.95 |
| 应交税费 | 5,598,091.53 | 4,117,056.98 | 2,900,752.59 | 7,905,876.07 |
| 其他应付款合计 | 11,373,964.31 | 10,784,102.09 | 24,306,146.39 | 14,821,123.34 |
| 一年内到期的非流动负债 | 20,910,079.72 | 21,563,035.44 | 13,692,313.87 | 13,998,445.42 |
| 其他流动负债 | - | - | 1,298.62 | 1,298.62 |
| 流动负债合计 | 283,773,202.65 | 304,476,883.57 | 280,793,841.33 | 296,218,922.31 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 8,000,000 | 8,000,000 |
| 租赁负债 | 11,654,169.7 | 10,669,879.26 | 15,603,350.02 | 17,041,386.32 |
| 预计负债 | 18,732,417.3 | 20,740,194.06 | 41,782,632.6 | 42,269,563.63 |
| 递延收益 | 4,609,826.06 | 4,615,185.23 | 3,840,544.4 | 3,845,903.57 |
| 递延所得税负债 | 46,103,065.38 | 46,583,260.43 | 46,990,984.41 | 47,322,267.5 |
| 非流动负债合计 | 81,099,478.44 | 82,608,518.98 | 116,217,511.43 | 118,479,121.02 |
| 负债合计 | 364,872,681.09 | 387,085,402.55 | 397,011,352.76 | 414,698,043.33 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 441,284,352 | 441,284,352 | 441,284,352 | 441,284,352 |
| 资本公积 | 2,716,551,157.4 | 2,716,551,157.4 | 2,716,551,157.4 | 2,716,551,157.4 |
| 减:库存股 | 50,008,969.51 | 46,356,166.77 | - | - |
| 盈余公积 | 25,102,306.36 | 25,102,306.36 | 25,102,306.36 | 25,102,306.36 |
| 未分配利润 | -1,514,344,007.37 | -1,485,877,113.61 | -1,458,195,906.09 | -1,433,046,218.31 |
| 归属于母公司股东权益合计 | 1,618,584,838.88 | 1,650,704,535.38 | 1,724,741,909.67 | 1,749,891,597.45 |
| 少数股东权益 | 10,790,133.44 | 11,746,774.19 | 13,323,882.75 | 14,527,033.69 |
| 股东权益合计 | 1,629,374,972.32 | 1,662,451,309.57 | 1,738,065,792.42 | 1,764,418,631.14 |
| 负债和股东权益合计 | 1,994,247,653.41 | 2,049,536,712.12 | 2,135,077,145.18 | 2,179,116,674.47 |
| 公告日期 | 2026-10-23 | 2026-08-15 | 2026-04-30 | 2026-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |